Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices 31237 

Atlanta, Georgia 30309. Comments can 

also be sent electronically to 

Applications.Comments@atl.frb.org: 

1. Heart of Georgia Bancshares, Inc., 

Vidalia, Georgia; to acquire Bank of 

Lumber, Lumber City, Georgia. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2022–11008 Filed 5–20–22; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). If the proposal also 

involves the acquisition of a nonbanking 

company, the review also includes 

whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843), and interested persons 

may express their views in writing on 

the standards enumerated in section 4. 

Unless otherwise noted, nonbanking 

activities will be conducted throughout 

the United States. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than June 22, 2022. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Fidelity Federal Bancorp, 

Evansville, Indiana; to become a bank 

holding company by acquiring 

Community Banks of Shelby County, 

Cowden, Illinois, and also to retain 

United Fidelity Bank, F.S.B., Evansville, 

Indiana, and thereby engage in 

operating a savings association pursuant 

to section 225.28(b)(4)(ii) of the Board’s 

Regulation Y. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2022–11011 Filed 5–20–22; 8:45 am] 

BILLING CODE P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Savings and Loan Holding 

Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Home Owners’ Loan Act 

(12 U.S.C. 1461 et seq.) (HOLA), 

Regulation LL (12 CFR part 238), and 

Regulation MM (12 CFR part 239), and 

all other applicable statutes and 

regulations to become a savings and 

loan holding company and/or to acquire 

the assets or the ownership of, control 

of, or the power to vote shares of a 

savings association. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on 

whether the proposed transaction 

complies with the standards 

enumerated in the HOLA (12 U.S.C. 

1467a(e)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than June 22, 2022. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Fidelity Federal Bancorp, 

Evansville, Indiana; to become a savings 

and loan company, following its 

conversion to a bank holding company 

for a moment in time in connection with 

its acquisition of Community Banks of 

Shelby County, Cowden, Illinois. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2022–11009 Filed 5–20–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–0009; Docket No. CDC–2022– 

0069] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled National Disease 

Surveillance Program. This collection 

covers the surveillance activities for 

four rare disease conditions; 

Creutzfeldt-Jakob Disease (CJD), Reye 

Syndrome, Kawasaki Syndrome, and 

Acute Flaccid Myelitis (AFM). 

DATES: CDC must receive written 

comments on or before July 22, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0069 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 


lotter on DSK11XQN23PROD with NOTICES1
31238 Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Disease Surveillance 

Program (OMB Control No. 0920–0009, 

Exp. 8/31/2022)—Revision—National 

Center for Emerging and Zoonotic 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Surveillance of the incidence and 

distribution of disease has been an 

important function of the U.S. Public 

Health Service (PHS) since an 1878 Act 

of Congress authorized the PHS to 

collect morbidity reports. After the 

Malaria Control in War Areas Program 

had fulfilled its original 1942 objective 

of reducing malaria transmission, its 

basic tenets were carried forward and 

broadened by the formation of the 

Communicable Disease Center (CDC) in 

1946. CDC was conceived of as a wellequipped, broadly staffed agency used 

to translate facts about analysis of 

morbidity and mortality statistics on 

communicable diseases and through 

field investigations. It was soon 

recognized that control measures (such 

as the DDT spraying for malaria) did not 

alleviate the threat of disease 

reintroduction. In 1950, the Malaria 

Surveillance Program began and in 

1952, the National Surveillance Program 

started. Both programs were based on 

the premise that diseases cannot be 

diagnosed, prevented, or controlled 

until existing knowledge is expanded 

and new ideas developed and 

implemented. The original scope of the 

National Surveillance Program included 

the study of malaria, murine typhus, 

smallpox, psittacosis, diphtheria, 

leprosy, and sylvatic plague. Over the 

years, the mandate of CDC has 

broadened in preventive health 

activities and the surveillance systems 

maintained have expanded. 

The National Disease Surveillance 

Program is authorized under the Public 

Health Service Act, Section 301 and 306 

(42 U.S.C. 241 and 242K). This 

information collection activity covers 

surveillance activities for four, rare 

diseases: (1) Creutzfeldt-Jakob Disease 

(CJD), (2) Reye Syndrome, (3) Kawasaki 

Syndrome, and (4) Acute Flaccid 

Myelitis. Since the previous approval of 

0920–0009, changes are being requested 

only to the Acute Flaccid Myelitis form. 

The total estimated burden requested by 

CDC has been reduced to 98, down 69 

hours from the previous total of 167, 

and is adjusted to match actual, 

experienced burden more closely. There 

is no cost to respondents other than the 

time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Epidemiologist ................................... CJD .................................................. 10 2 20/60 7 

Kawasaki Syndrome ........................ 20 2 15/60 10 

Reye Syndrome1 ............................. 1 1 20/60 1 

Acute Flaccid Myelitis ...................... 100 4 12/60 80 

Total ........................................... ........................................................... ........................ ........................ ........................ 98 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–10991 Filed 5–20–22; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1